Back to DE D. E. Shaw & Co., Inc.

XERSXERS
Showing 8 of 18 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in XERIS BIOPHARMA HOLDINGS INC

D. E. Shaw & Co., Inc. holds 7.8M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $61.8M as of 2026-Q2. The position was increased (+0.2% shares). XERS represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$61.8M

Current Shares

7.8M

Total Value Change

+$59M

Total Shares Change

+6.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.8M
+0.2%
$61.8M0.0%$7.92
29
2026-Q1
Increased
7.8M
+2.8%
$45.2M0.0%$5.94
30
2025-Q4
Increased
7.6M
+29.7%
$59.5M0.0%$7.31
37
2025-Q3
Increased
5.8M
+52.3%
$47.5M0.0%$8.08
41
2025-Q2
Increased
3.8M
+25.6%
$17.9M0.0%$4.70
35
2025-Q1
Increased
3.1M
+123.9%
$16.8M0.0%$5.58
46
2024-Q4
Increased
1.4M
+38.4%
$4.6M0.0%$3.38
35
2024-Q3
Increased
985,015
+90.2%
$2.8M0.0%$2.87
41

Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used